Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.2112 (0.83%) ($6.0800 - $6.3200) on Wed. Jul. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 67 | Latest Price | $6.2112(0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.6% a day on average for past five trading days. | Weekly Trend | EYES advances 0.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) IGOV(6%) UNG(6%) FIVG(5%) ICLN(5%) | Factors Impacting EYES price | EYES will decline at least -2.415% in a week (0% probabilities). BND(-8%) VCIT(-6%) LQD(-6%) XLP(-5%) XLK(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
5 Day Moving Average | $6.26(-0.78%) | 10 Day Moving Average | $6.33(-1.88%) | 20 Day Moving Average | $6.14(1.16%) | To recent high | -31.9% | To recent low | 19.1% | Market Cap | $1.984b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |